In the cohort analyzed (n¼1,028,125), the prevalence of epilepsy was 0.44% (n¼4,528). Overall, 55% (n¼2,508) received any of these AEDs during pregnancy, the most common of which were lamotrigine (49.8%) and levetiracetam (42.5%). Compared to the non-epileptic control group, women on AEDs showed significant increases in the absolute risk of cesarean delivery (5.0%), preeclampsia (0.7%), severe preeclampsia/eclampsia (0.9%) and SMM (1.6%). AEDs with the highest increases in absolute risk were topiramate (6.7%) for cesarean delivery, lamotrigine for pre-eclampsia (1.1%), and lacosamide for severe preeclampsia/eclampsia (8.4%) and SMM (9.3%). Of the 2,508 women, 414 (16.5%) received more than one AED during pregnancy. Compared to women receiving a single AED, those who received multiple AEDs had higher absolute risks of all outcomes except postpartum hemorrhage (Table) . CONCLUSION: Compared to non-epileptic women, women on newer generation AEDs demonstrated an increased absolute risk for cesarean delivery, preeclampsia, severe preeclampsia/eclampsia and severe maternal morbidity. Women receiving multiple medications demonstrated the highest increase in absolute risk for adverse outcomes, similar to findings in older AEDs, possibly also reflecting a more complicated and difficult disease state.
514 Postpartum readmission for hypertensive diseases of pregnancy after a delivery hospitalization without preeclampsia or hypertension (Table) . Over 90% of readmissions occurred within 20 days of discharge (Figure) . Among women without prior HDP diagnosis, severe morbidity occurred in 13.6% of readmissions. Risk for severe morbidity among readmitted women with HDP or cHTN at delivery was significantly lower (6.5%, p<0.01). Women readmitted without prior HDP diagnosis were also at significantly higher risk for eclampsia (p<0.01). CONCLUSION: Women readmitted postpartum for HDP without a hypertension diagnosis at delivery are at high risk for severe morbidity both absolutely and compared to women with prior diagnoses of HDP and cHTN. Many of these readmissions occur soon after hospital discharge. Close post-discharge follow-up for at-risk women may be important to reduce readmission-associated maternal morbidity.
515 Antepartum hospitalizations for hypertensive diseases of pregnancy and risk for subsequent postpartum readmission
